Amikacin

Biology

Mycobacterium tuberculosis

Mycobacterium Infections

Antimicrobial

Antimycobacterial

Mycobacterium

Clarithromycin

Nontuberculous mycobacteria

Rifabutin

Clinical microbiology

Antibiotics

Microbiology

Tuberculosis

Medicine

Pathology

Journal of Clinical Microbiology

Recommendations for first-line and second-line drug testing and organism group, specific methodologies, and reporting recommendations have been addressed by the Clinical and Laboratory Standards Institute (CLSI) and are important in the selection of appropriate antimicrobial treatment regimens for nontuberculous mycobacteria (NTM) disease. This review also includes recent information on new antimicrobials proposed for the treatment of NTM but not yet addressed by the CLSI and molecular (gene sequencing) methods associated with the detection of antimicrobial resistance of two major therapeutic antimicrobials, clarithromycin and amikacin.

Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria